BioSpace News Archive

Business

Leading Alzheimer’s Disease Scientist Joins NeuroCog Trials

Dr. Kathleen Anne Welsh-Bohmer, Professor of Psychiatry and Neurology at Duke University, joins the accomplished scientific team at NeuroCog Trials (NCT) providing thought leadership in Neurodegenerative Disorders.

July 9, 2018
·
2 min read
Drug Development

TLC Reports Last Patient Last Visit (LPLV) in TLC599 Phase II Trial and FDA Clearance to Commence New Clinical Trials

LPLV marks the final steps toward completion of TLC599 trial for osteoarthritis (OA) pain Phase II topline results on-track for 2018 release Set to initiate enrollment of US Phase II pharmacokinetic (PK) trial for TLC599 Clearance received from the U.S. Food and Drug Administration (FDA) for the TLC590 and TLC178 Investigational New Drug (IND) applications, allowing Phase I/II trials to proceed in the...

July 9, 2018
·
6 min read
Policy

Battelle and Triad Team Partners Awarded New Contract to Manage and Operate Los Alamos National Laboratory

Department of Energy’s National Nuclear Security Administration selects Triad National Security for $25 billion contract

July 9, 2018
·
4 min read
Deals

Spero Therapeutics Announces Proposed Offering of Common Stock

Spero Therapeutics, Inc. announced that it has commenced an underwritten public offering of 4,500,000 shares of its common stock.

July 9, 2018
·
3 min read
Business

Exact Sciences to host annual meeting, second-quarter 2018 results webcasts and calls

Exact Sciences Corp. announced that the company will host webcasts and conference calls of its annual stockholders meeting and to discuss its second-quarter 2018 financial results.

July 9, 2018
·
5 min read
Business

Michael Amoroso to Join Kite as Senior Vice President and Head of Worldwide Commercial, Cell Therapy

Mr. Amoroso Brings Significant Expertise in Oncology to New Role

July 9, 2018
·
3 min read
Policy

Bragar Eagel & Squire, P.C. is Investigating ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

July 9, 2018
·
1 min read
Drug Development

Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia

Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a phase III, randomized, double-blind, multi-center clinical study (BELIEVE).

July 9, 2018
·
6 min read
Policy

Advisory - Several drugs containing valsartan being recalled due to contamination with a potential carcinogen

Several drugs containing the ingredient valsartan are being recalled by their manufacturers.

July 9, 2018
·
5 min read
Business

Canntab announces collaboration and profit sharing agreement with FSD Pharma to produce and market oral dose delivery platforms

Canntab Therapeutics Limited is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) with FSD Pharma Inc.

July 9, 2018
·
6 min read